Core and Group Health

Following Biden's $35 cap on insulin costs for seniors on Medicare and three pharma companies agreeing to the cost reduction, Amazon is now giving its online customers instant discounts for the diabetes drug.

Hospital system AdventHealth has filed a lawsuit against MultiPlan, alleging the cost-management firm has systematically underpaid hospitals and doctors at least $19 billion per year for out-of-network reimbursements.

To protect public health, at least 15 products manufactured by Universal Meditech are being recalled over "concerns that the tests may not be safe and effective," according to the Food and Drug Administration.

In a large clinical trial, Novo Nordisk's new obesity drug reduced the risk of serious heart problems by 20% - a landmark finding that could put more pressure on insurers to cover the high costs of these new medications.

The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer's and a precursor condition, mild cognitive impairment.

A group of four bipartisan senators, including Sen. Charles Grassley, sent a letter to tax commissioners over concerns that these hospitals may not be providing charity care to communities as required for their tax-exempt status.